News

NEWS

SOTIO opens office in Basel, Switzerland, to accelerate development of its pipeline products

SOTIO, a biotechnology company owned by the PPF Group, announce today the opening of offices of SOTIO Biotech AG at the Technology Park Basel, Switzerland. The SOTIO office will host the clinical development team, as well as other functions to progress its broad clinical development pipeline towards filing for marketing authorization and commercial launch.

This website uses cookies; by continuing to use this page, you consent to their use. About cookies